Dual RAS/SHP2 inhibition for sensitization of pancreatic cancer to immunotherapy (P17)

• Subject Area: Hematology, Oncology ; General and Visceral Surgery ; Gastroenterology ; Clinical Immunology and Allergology
• Term: since 2021
• Project identifier: Deutsche Forschungsgemeinschaft (DFG) - Project number 441891347

No abstract available

• DFG Programme: Collaborative Research Centres
• Subproject of: SFB 1479: Oncogene-driven immune escape (OncoEscape)
• Applicant Institution: Albert-Ludwigs-Universität Freiburg
• Project Heads: Professor Bertram Bengsch, Ph.D., since 1/2026; Privatdozent Dr. Dietrich Ruess